Efficacy and safety of metallic stents in patients with unresectable pancreatic cancer receiving gemcitabine

被引：0
|
作者：
Nakai, Yousuke
Isayama, Hiroyuki
Tsujino, Takeshi
Yoshida, Haruhiko
Kawabe, Takao
Yagioka, Hiroshi
Kogure, Hirofumi
Sasaki, Takashi
Ito, Yukiko
Togawa, Osamu
Matsubara, Saburou
Arizumi, Toshihiko
Sasahira, Naoki
Hirano, Kenji
Matsubara, Minoru
Omata, Masao
机构：
来源：
GASTROINTESTINAL ENDOSCOPY | 2007年 / 65卷 / 05期
关键词：
D O I：
10.1016/j.gie.2007.03.487
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：AB226 / AB226
页数：1
相关论文
共 50 条
  • [31] A randomized phase II, double-blind study to evaluate the efficacy and safety of galunisertib plus gemcitabine (GG) or gemcitabine plus placebo (GP) in patients with unresectable pancreatic cancer (PC)
    Melisi, Davide
    Garcia-Carbonero, Rocio
    Macarulla, Teresa
    Pezet, Denis
    Deplanque, Gael
    Fuchs, Martin
    Trojan, Joerg
    Oettle, Helmut
    Kozloff, Mark
    Cleverly, Ann
    Gueorguieva, Ivelina
    Desaiah, Durisala
    Lahn, Michael M.
    Al Blunt
    Benhadji, Karim A.
    Tabernero, Josep
    CANCER RESEARCH, 2016, 76
  • [32] A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer
    Oettle, H
    Richards, D
    Ramanathan, RK
    van Laethem, JL
    Peeters, M
    Fuchs, M
    Zimmermann, A
    John, W
    Von Hoff, D
    Arning, M
    Kindler, HL
    ANNALS OF ONCOLOGY, 2005, 16 (10) : 1639 - 1645
  • [33] Efficacy of gemcitabine combined with hyperthermia therapy in the treatment of unresectable pancreatic cancer: Phase II study
    Tsuchiya, Reiko
    Ishikawa, Takeshi
    Okajima, Manabu
    Matsuyama, Tatsuzo
    Yoshida, Naohisa
    Katada, Kazuhiro
    Kamada, Kazuhiro
    Sakamoto, Naoyuki
    Uchiyama, Kazuhiko
    Handa, Osamu
    Takagi, Tomohisa
    Ysuda, Hiroaki
    Sakagami, Jyunichi
    Konishi, Hideyuki
    Yagi, Nobuaki
    Kokura, Satoshi
    Naito, Yuji
    CANCER RESEARCH, 2012, 72
  • [34] Efficacy of Covered Metallic Stents in the Treatment of Unresectable Malignant Biliary Obstruction
    Shiro Miyayama
    Osamu Matsui
    Yukari Akakura
    Toru Yamamoto
    Hiroto Nishida
    Kenji Yoneda
    Keiichi Kawai
    Daisyu Toya
    Nobuyoshi Tanaka
    Takeshi Mitsui
    Yasuyuki Asada
    CardioVascular and Interventional Radiology, 2004, 27 : 349 - 354
  • [35] The safety and efficacy of pancreatic duct stents in patients with acute biliary pancreatitis
    Hisai, Hiroyuki
    Koshiba, Yutaka
    Hirako, Tasuku
    Ikeda, Yuuki
    Arihara, Yohei
    Miyazaki, Etsu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 428 - 428
  • [36] Efficacy of covered metallic stents in the treatment of unresectable malignant biliary obstruction
    Miyayama, S
    Matsui, O
    Akakura, Y
    Yamamoto, T
    Nishida, H
    Yoneda, K
    Kawai, K
    Toya, D
    Tanaka, N
    Mitsui, T
    Asada, Y
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2004, 27 (04) : 349 - 354
  • [37] Efficacy of gemcitabine in advanced unresectable biliary tract cancer
    Mehrotra, B
    Ahmed, S
    Bhargava, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 377S - 377S
  • [38] Efficacy and safety of uncovered self-expandable metal stents for distal malignant biliary obstruction in unresectable non-pancreatic cancer
    Niiya, Fumitaka
    Tamai, Naoki
    Yamawaki, Masataka
    Noda, Jun
    Azami, Tetsushi
    Takano, Yuichi
    Nishimoto, Fumiya
    Nagahama, Masatsugu
    DEN OPEN, 2025, 5 (01):
  • [39] Safety and efficacy of gemcitabine plus nab-paclitaxel therapy in elderly patients with advanced pancreatic cancer
    Aoki, Yu
    Sukawa, Yasutaka
    Kawasaki, Kenta
    Suzuki, Takeshi
    Hirata, Kenro
    Kasuga, Akiyoshi
    Iwasaki, Eisuke
    Hamamoto, Yasuo
    Takaishi, Hiromasa
    Kanai, Takanori
    ANNALS OF ONCOLOGY, 2017, 28
  • [40] Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer
    Davide Melisi
    Rocio Garcia-Carbonero
    Teresa Macarulla
    Denis Pezet
    Gael Deplanque
    Martin Fuchs
    Jorg Trojan
    Helmut Oettle
    Mark Kozloff
    Ann Cleverly
    Claire Smith
    Shawn T. Estrem
    Ivelina Gueorguieva
    Michael M. F. Lahn
    Al Blunt
    Karim A. Benhadji
    Josep Tabernero
    British Journal of Cancer, 2018, 119 : 1208 - 1214
12345